1509p * additional haemoglobin (hb) and quality of life (qol) analyses from eaqua

Conclusions: In our study, many pts treated with DA per current European indication for symptomatic CIA had Hb increases ≥1 g/dL and/or QoL improvements within 6 weeks of starting treatment. QoL/Hb improvements were observed across tumour types. Relatively few pts required transfusions or iron supplementation during the study.Disclosure: G. Tonini: received Research funding from Amgen for eAQUA participation; J. Mouysset, M. Rotarski, M. Airoldi, C. Toganel and C. Christofyllakis: has received research funding from Amgen for eAQUA participation; D. Spaeth: has received research funding from Amgen for eAQUA participation and honoraria for symposia participation from Amgen; L. Belton: is a contractor funded by Amgen; C. Bohac: is an Amgen Inc. employee and stockholder; J. Terwey: is an Amgen (Europe) GmbH employee and stockholder.

Source: Annals of Oncology - September 24, 2014 Category: Cancer & Oncology Authors: Tonini, G., Mouysset, J., Rotarski, M., Spaeth, D., Airoldi, M., Toganel, C., Christofyllakis, C., Belton, L., Bohac, C., Terwey, J. Tags: supportive care Source Type: research